Although increased TGFβ-1 synthesis was observed in previous reports of different types of advanced lung cancer models, but on the contrary, in some primary lung cancer studies reduced or steady levels of this cancer promoter/suppressor marker was reported along with increased cell matrix interactions, suppressed immune surveillance, or increased angiogenic activity. This evidence concerns the gene TGFB1 and cancer.